Abstract:Currently, most of the basic mechanisms governing tumor-immune system interactions, in combination with modulations of tumor-associated vasculature, are far from being completely understood. Here, we propose a mathematical model of vascularized tumor growth, where the main novelty is the modeling of the interplay between functional tumor vasculature and effector cell recruitment dynamics. Parameters are calibrated on the basis of different in vivo immunocompromised Rag1-/- and wild-type (WT) BALB/c murine tumor growth experiments. The model analysis supports that tumor vasculature normalization can be a plausible and effective strategy to treat cancer when combined with appropriate immuno-stimulations. We find that improved levels of functional tumor vasculature, potentially mediated by normalization or stress alleviation strategies, can provide beneficial outcomes in terms of tumor burden reduction and growth control. Normalization of tumor blood vessels opens a therapeutic window of opportunity to augment the antitumor immune responses, as well as to reduce the intratumoral immunosuppression and induced-hypoxia due to vascular abnormalities. The potential success of normalizing tumor-associated vasculature closely depends on the effector cell recruitment dynamics and tumor sizes. Furthermore, an arbitrary increase of initial effector cell concentration does not necessarily imply a better tumor control. We evidence the existence of an optimal concentration range of effector cells for tumor shrinkage. Based on these findings, we suggest a theory-driven therapeutic proposal that optimally combines immuno- and vaso-modulatory interventions.

Vascular Normalization: a Strategy to Recondition the Tumor Immune Microenvironment

[Vascular Normalization and Cancer Immunotherapy].

Vascular Normalization As an Emerging Strategy to Enhance Cancer Immunotherapy.

Tumor Vessel Normalization: A Window to Enhancing Cancer Immunotherapy

Targeting vascular normalization: a promising strategy to improve immune-vascular crosstalk in cancer immunotherapy

Normalization of the tumor microenvironment by harnessing vascular and immune modulation to achieve enhanced cancer therapy

Inducing Vascular Normalization: A Promising Strategy for Immunotherapy.

Vascular normalization: reshaping the tumor microenvironment and augmenting antitumor immunity for ovarian cancer

Towards Immunotherapy-Induced Normalization of the Tumor Microenvironment

Manipulation of immune‒vascular crosstalk: new strategies towards cancer treatment

Targeting Vegf Pathway To Normalize The Vasculature: An Emerging Insight In Cancer Therapy

Normalization of tumor vasculature: A potential strategy to increase the efficiency of immune checkpoint blockades in cancers

Tumor Vasculatures: A New Target for Cancer Immunotherapy

Tumor vascular normalization improves cancer treatment efifcacy

Improving Immune–vascular Crosstalk for Cancer Immunotherapy

Tumor vasculature and microenvironment normalization: a possible mechanism of antiangiogenesis therapy.

Alleviating hypoxia to improve cancer immunotherapy

Vascular normalisation as the stepping stone into tumour microenvironment transformation

Reinforcing vascular normalization therapy with a bi-directional nano-system to achieve therapeutic-friendly tumor microenvironment

Normalization in tumor ecosystem: Opportunities and challenges

Cancer therapeutic potential of combinatorial immuno- and vaso-modulatory interventions